PRESS RELEASE
News
-
-
-
-
-
-
PRESS RELEASE
3Win Corp. Executes Definitive Agreement to Acquire Serenus Global, Inc.
3Win Corp., a global wholesale distributor of CCELL vape products, announces the acquisition of Serenus Global, a multi-disciplinary controlled substances company, to expand into new markets. The acquisition is expected to close on December 12, 2023. For more information, visit www.3wincorp.com and www.serenusglobal.com -
PRESS RELEASE
Expert Panel Provides Updated Data for Epilepsy and Pregnancy
The Epilepsy & Pregnancy Medical Consortium (EPMC) updates best practice recommendations for epilepsy patients considering pregnancy based on the groundbreaking MONEAD study, providing guidance on safe anti-seizure medications and breastfeeding -
-
-
PRESS RELEASE
Cytonus Secures Series A Financing to Advance Pipeline of Novel Cargocyte(TM)-Based Medicines
Cytonus Therapeutics, Inc. secures $11.7 million Series A funding led by Partners Investment with a group of new investors to advance its pipeline of novel medicines enabled by its proprietary Cargocyte™ Drug Delivery Platform. The funds will be used for portfolio development targeting metastatic tumors and the central nervous system (CNS)
